Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ultrasound-Guided Botox for TMJ Anterior Disc Displacement
NCT07076355Completed
- Sponsor
- Tanta University
- Start
- May 2024
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of botulinum toxin type A in Anterior disc displacement with reduction (ADDwR), sponsored by Tanta University. Primary endpoint: Numerical Pain Rating Scale at 24 weeks. Started May 2024; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Anterior disc displacement with reduction (ADDwR)
Beyond the preview
Go deeper on NCT07076355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07076355.